Blaes F, Strittmatter M, Merkelbach S, et al. (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol 246:299-303
Budde-Steffen C, Anderson NE, Rosenblum MK, et al. (1988) An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23:528-531
Cher LM, Hochberg FH, Teruya J, et al. (1995) Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 75:1678-83
Graus F, Vega F, Delattre JY, et al. (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536-40
Keime-Guibert F, Graus F, Fleury A, et al. (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479-82
Luque FA, Furneaux HM, Ferziger R, et al. (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241-251
Martinaud O, Guegan-Massardier E, Iasci L, et al. (2005) Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia. Rev Neurol (Paris) 161:81-86
Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580-7
Rajabally YA, Naz S, Farrell D, Abbott RJ (2004) Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies. J Neurol 251:1528-9
Shams'ili S, Grefkens J, de Leeuw B, et al. (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409-1418
Stark E, Wurster U, Patzold U, et al. (1995) Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 52:814-8
Uchuya M, Graus F, Vega F, et al. (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60:388-92
Vernino S, O'Neill BP, Marks RS, et al. (2004) Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neurooncol 6:55-62
Voltz R (2002) Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1:294-305
Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH (2003) Response to intravenous immunoglobulin in anti-Yo associated Paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 63:187-90
